EPIVAX, INC.
Providence, RI · Biotech · Acquired
ISPRI-HCP platform for assessing T cell immunogenicity risk of process-related protein impurities in biologic drugs
epivax.com →- Grants
- $1.8M
- 8 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 40
- 18 granted · 22 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201620172018201920202021202220232024
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Development of a Non-adjuvanted VLP Vaccine against Stealth H7N9 Influenza | $300,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Development of a Non-adjuvanted VLP Vaccine against Stealth H7N9 Influenza | $290,546 | |
| Federal grant | Department of Health and Human Services · Phase I · Novel Antigen-Specific Immunomodulatory Tregitope-based Therapy to Address Autoimmune Pathogenesis in Graves' Disease | $177,020 | |
| Federal grant | Department of Health and Human Services · Phase I · GAA-ITEM: Personalizing the Prediction of Anti-therapeutic Antibody Response in Pompe Disease Patients | $191,402 | |
| Federal grant | Department of Health and Human Services · Phase I · Novel Antigen-Specific Immunomodulatory Tregitope-based Therapy to Address Autoimmune Pathogenesis in Graves' Disease | $139,842 | |
| Federal grant | Department of Health and Human Services · Phase I · GAA-ITEM: Personalizing the Prediction of Anti-therapeutic Antibody Response in Pompe Disease Patients | $133,578 | |
| Federal grant | Department of Health and Human Services · Phase I · Validation and Improvement of ISPRI-HCP: An Innovative Platform for Immunogenicity Risk Assessment of Process-related Protein Impurities | $299,917 | |
| Federal grant | Department of Health and Human Services · Phase I · PA21259, SBIR, Phase I, Improving T cell Responses in Vaccines: Prediction and Validation Using Existing Databases, Immunoinformatics and In Vitro Assays | $299,930 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 3102 | Medical Guidance Systems LLC | — | — |
| 3103 | TRIANGLE THERAPEUTICS INC. | — | — |
| 3104 | Thimble Therapeutics Inc | — | — |
| 3105 | EPIVAX, INC. | — | — |
| 3106 | Cortendo | — | — |
| 3107 | MICROPURE GENOMICS INC | — | — |
| 3108 | ERNEST PHARMACEUTICALS LLC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Peptides For Inducing Heterosubtypic Influenza T Cell Responsesgranted
- Regulatory T Cell Epitopesapplication
- Regulatory T Cell Epitopes, Compositions And Uses Thereofgranted
- Retro - Inverso Regulatory T Cell Epitopesapplication
- Regulatory T Cell Epitopesgranted
- Regulatory T Cell Epitopes, Compositions And Uses Thereofgranted
- Regulatory T Cell Epitopesapplication
- Regulatory T Cell Epitopesapplication
- Regulatory T Cell Epitopes And Detolerized SARS-COV-2 Antigensapplication
- Epitopic Vaccine For African Swine Fever Virusapplication
- T Cell Epitopes And Related Compositions Useful In The Prevention, Diagnosis, And Treatment Of COVID-19application
- Tregitope Constructs Useful In The Prevention And Treatment Of Type 1 Diabetesapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.